Upgrade to SI Premium - Free Trial

Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,050 at Goldman Sachs

July 23, 2026 3:07 AM
Goldman Sachs analyst Shyam Srinivasan lowered the price target on Dr. Reddy\'s Laboratories (DRRD:IN) (NYSE: RDY) to INR1,050.00 (from INR1,075.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Intl Ratings